Alumis Inc Net Income
| ALMS Stock | 26.54 0.26 0.97% |
As of the 15th of February 2026, Alumis shows the Mean Deviation of 6.01, downside deviation of 4.1, and Risk Adjusted Performance of 0.2022. Alumis Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Alumis Inc variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Alumis Inc is priced correctly, providing market reflects its regular price of 26.54 per share. Given that Alumis has jensen alpha of 3.02, we suggest you to validate Alumis Inc's prevailing market performance to make sure the company can sustain itself at a future point.
Alumis' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Alumis' valuation are provided below:Gross Profit | Market Capitalization | Enterprise Value Revenue 134.2894 | Revenue | Earnings Share (2.15) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -264.8 M | -278.1 M | |
| Net Loss | -264.8 M | -278.1 M | |
| Net Loss | (9.34) | (9.81) |
Alumis | Net Income | Build AI portfolio with Alumis Stock |
The evolution of Net Income for Alumis Inc provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Alumis compares to historical norms and industry peers.
Latest Alumis' Net Income Growth Pattern
Below is the plot of the Net Income of Alumis Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Alumis Inc financial statement analysis. It represents the amount of money remaining after all of Alumis Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Alumis' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alumis' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (294.23 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Alumis Net Income Regression Statistics
| Arithmetic Mean | (143,951,523) | |
| Coefficient Of Variation | (45.50) | |
| Mean Deviation | 48,974,093 | |
| Median | (111,930,000) | |
| Standard Deviation | 65,491,173 | |
| Sample Variance | 4289.1T | |
| Range | 182.3M | |
| R-Value | (0.70) | |
| Mean Square Error | 2328.1T | |
| R-Squared | 0.49 | |
| Significance | 0 | |
| Slope | (9,088,854) | |
| Total Sum of Squares | 68625.5T |
Alumis Net Income History
Other Fundumenentals of Alumis Inc
Alumis Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Alumis is extremely important. It helps to project a fair market value of Alumis Stock properly, considering its historical fundamentals such as Net Income. Since Alumis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Alumis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Alumis' interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Biotechnology market expansion? Will Alumis introduce new products? Factors like these will boost the valuation of Alumis. If investors know Alumis will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Alumis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Alumis Inc's market price often diverges from its book value, the accounting figure shown on Alumis's balance sheet. Smart investors calculate Alumis' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Alumis' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Alumis' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alumis represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Alumis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Alumis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alumis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alumis.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Alumis on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Alumis Inc or generate 0.0% return on investment in Alumis over 90 days. Alumis is related to or competes with RAPT Therapeutics, Neumora Therapeutics, ADC Therapeutics, Ocugen, Eton Pharmaceuticals, Omeros, and Fulcrum Therapeutics. Alumis is entity of United States. It is traded as Stock on NASDAQ exchange. More
Alumis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alumis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alumis Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.1 | |||
| Information Ratio | 0.2337 | |||
| Maximum Drawdown | 103.99 | |||
| Value At Risk | (7.19) | |||
| Potential Upside | 10.41 |
Alumis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alumis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alumis' standard deviation. In reality, there are many statistical measures that can use Alumis historical prices to predict the future Alumis' volatility.| Risk Adjusted Performance | 0.2022 | |||
| Jensen Alpha | 3.02 | |||
| Total Risk Alpha | 2.15 | |||
| Sortino Ratio | 0.7469 | |||
| Treynor Ratio | 1.95 |
Alumis February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2022 | |||
| Market Risk Adjusted Performance | 1.96 | |||
| Mean Deviation | 6.01 | |||
| Semi Deviation | 2.82 | |||
| Downside Deviation | 4.1 | |||
| Coefficient Of Variation | 418.4 | |||
| Standard Deviation | 13.1 | |||
| Variance | 171.57 | |||
| Information Ratio | 0.2337 | |||
| Jensen Alpha | 3.02 | |||
| Total Risk Alpha | 2.15 | |||
| Sortino Ratio | 0.7469 | |||
| Treynor Ratio | 1.95 | |||
| Maximum Drawdown | 103.99 | |||
| Value At Risk | (7.19) | |||
| Potential Upside | 10.41 | |||
| Downside Variance | 16.79 | |||
| Semi Variance | 7.93 | |||
| Expected Short fall | (7.81) | |||
| Skewness | 5.68 | |||
| Kurtosis | 38.82 |
Alumis Inc Backtested Returns
Alumis is slightly risky given 3 months investment horizon. Alumis Inc secures Sharpe Ratio (or Efficiency) of 0.23, which signifies that the company had a 0.23 % return per unit of risk over the last 3 months. We have collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 3.17% are justified by taking the suggested risk. Use Alumis Risk Adjusted Performance of 0.2022, downside deviation of 4.1, and Mean Deviation of 6.01 to evaluate company specific risk that cannot be diversified away. Alumis holds a performance score of 18 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.6, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Alumis will likely underperform. Use Alumis value at risk, as well as the relationship between the skewness and day median price , to analyze future returns on Alumis.
Auto-correlation | 0.77 |
Good predictability
Alumis Inc has good predictability. Overlapping area represents the amount of predictability between Alumis time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alumis Inc price movement. The serial correlation of 0.77 indicates that around 77.0% of current Alumis price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.77 | |
| Spearman Rank Test | 0.8 | |
| Residual Average | 0.0 | |
| Price Variance | 23.97 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Alumis Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Alumis Inc reported net income of (294.23 Million). This is 186.21% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 151.53% higher than that of the company.
Alumis Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alumis' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alumis could also be used in its relative valuation, which is a method of valuing Alumis by comparing valuation metrics of similar companies.Alumis is currently under evaluation in net income category among its peers.
Alumis ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Alumis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Alumis' managers, analysts, and investors.Environmental | Governance | Social |
Alumis Fundamentals
| Return On Equity | -0.67 | ||||
| Return On Asset | -0.61 | ||||
| Operating Margin | (53.72) % | ||||
| Current Valuation | 2.97 B | ||||
| Shares Outstanding | 117.51 M | ||||
| Shares Owned By Insiders | 0.68 % | ||||
| Shares Owned By Institutions | 70.48 % | ||||
| Number Of Shares Shorted | 8.67 M | ||||
| Price To Book | 8.60 X | ||||
| Price To Sales | 149.60 X | ||||
| Gross Profit | 22.12 M | ||||
| EBITDA | (297.6 M) | ||||
| Net Income | (294.23 M) | ||||
| Total Debt | 30.72 M | ||||
| Book Value Per Share | 3.69 X | ||||
| Cash Flow From Operations | (255.08 M) | ||||
| Short Ratio | 1.46 X | ||||
| Earnings Per Share | (2.15) X | ||||
| Target Price | 37.25 | ||||
| Number Of Employees | 221 | ||||
| Market Capitalization | 3.31 B | ||||
| Total Asset | 340.99 M | ||||
| Retained Earnings | (658.55 M) | ||||
| Working Capital | 255.28 M | ||||
| Net Asset | 340.99 M |
About Alumis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alumis Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alumis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alumis Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alumis Stock Analysis
When running Alumis' price analysis, check to measure Alumis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alumis is operating at the current time. Most of Alumis' value examination focuses on studying past and present price action to predict the probability of Alumis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alumis' price. Additionally, you may evaluate how the addition of Alumis to your portfolios can decrease your overall portfolio volatility.